BG101582A - Piperazine derivatives, medicaments containing the same, their use and process for preparing the same - Google Patents

Piperazine derivatives, medicaments containing the same, their use and process for preparing the same

Info

Publication number
BG101582A
BG101582A BG101582A BG10158297A BG101582A BG 101582 A BG101582 A BG 101582A BG 101582 A BG101582 A BG 101582A BG 10158297 A BG10158297 A BG 10158297A BG 101582 A BG101582 A BG 101582A
Authority
BG
Bulgaria
Prior art keywords
same
preparing
piperazine derivatives
medicaments containing
salts
Prior art date
Application number
BG101582A
Other languages
Bulgarian (bg)
English (en)
Inventor
Helmut Pieper
Volkhard Austel
Frank Himmelsbach
Guenter Linz
Brian Guth
Johannes Weisenberger
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19944446301 external-priority patent/DE4446301A1/de
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of BG101582A publication Critical patent/BG101582A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
BG101582A 1994-12-23 1997-06-06 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same BG101582A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19944446301 DE4446301A1 (de) 1994-12-23 1994-12-23 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19526678A DE19526678A1 (de) 1994-12-23 1995-07-21 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE1995133639 DE19533639A1 (de) 1994-12-23 1995-09-12 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP1995/005031 WO1996020173A1 (de) 1994-12-23 1995-12-19 Piperazinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BG101582A true BG101582A (en) 1998-01-30

Family

ID=27207101

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101582A BG101582A (en) 1994-12-23 1997-06-06 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same

Country Status (20)

Country Link
US (1) US5922717A (de)
EP (1) EP0799202A1 (de)
JP (1) JPH10511374A (de)
CN (1) CN1183770A (de)
AR (1) AR002950A1 (de)
AU (1) AU4432496A (de)
BG (1) BG101582A (de)
BR (1) BR9510360A (de)
CA (1) CA2207618A1 (de)
CZ (1) CZ189197A3 (de)
EE (1) EE9700141A (de)
FI (1) FI972646A (de)
HR (1) HRP950609A2 (de)
IL (1) IL116517A0 (de)
MX (1) MX9704745A (de)
NO (1) NO972881D0 (de)
PL (1) PL321003A1 (de)
SK (1) SK79797A3 (de)
TR (1) TR199501634A2 (de)
WO (1) WO1996020173A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796098A4 (de) * 1994-12-22 1998-04-29 Smithkline Beecham Corp Fibrinogenrezeptor-antagonisten
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
CA2229617A1 (en) * 1995-10-20 1997-05-01 Dr. Karl Thomae Gmbh 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
AU7675798A (en) 1998-04-09 1999-11-01 Meiji Seika Kaisha Ltd. Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof
EP1533310A1 (de) * 1999-09-29 2005-05-25 Ortho-McNeil Pharmaceutical, Inc. Isonipecotamide zur Behandlung von Integrin vermittelten Störungen
ES2244474T3 (es) * 1999-09-29 2005-12-16 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamida para el tratamiento de trastornos mediados por integrina.
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
US7081460B2 (en) * 2001-04-09 2006-07-25 Ortho-Mcneil Pharmaceutical, Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
JP2005504771A (ja) 2001-08-24 2005-02-17 エール ユニヴァーシティ 抗腫瘍・抗癌剤としてのピペラジノン化合物と処置方法
FR2829766A1 (fr) * 2001-09-14 2003-03-21 Lipha Derives d'oxamates comportant un heterocycle azote diversement substitue
US7482365B2 (en) 2002-02-08 2009-01-27 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
BRPI0508098A (pt) * 2004-02-27 2007-07-17 Amgen Inc compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
EP1909797A4 (de) * 2005-08-02 2013-02-27 Neurogen Corp Dipiperazinyl-ketone und damit verwandte analoge
WO2007053400A2 (en) * 2005-10-28 2007-05-10 Merck & Co., Inc. Piperidine glycine transporter inhibitors
EP2565183A1 (de) 2006-06-28 2013-03-06 Amgen Inc. Inhibitoren des Glycintransporters 1
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
CN101595100B (zh) 2007-01-16 2014-06-11 普渡制药公司 作为orl-1配体的杂环取代的哌啶
EP3564240B1 (de) * 2007-08-31 2022-04-06 Purdue Pharma L.P. Piperidinverbindungen als zwischenprodukte
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
PE20140868A1 (es) 2011-06-24 2014-07-18 Amgen Inc Antagonistas trpm8 y su uso en tratamientos
EP2723718A1 (de) 2011-06-24 2014-04-30 Amgen Inc. Trpm8-antagonisten und ihre verwendung bei behandlungen
JP2015508779A (ja) * 2012-02-16 2015-03-23 ニューヨーク・ユニバーシティ 低酸素状態で誘導可能な遺伝子発現の、オリゴオキソピペラジン非ペプチド性へリックス模倣体による制御
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
AU2014207311A1 (en) 2013-01-19 2015-08-20 New York University Oligooxopiperazines for p53 reactivation
AU2015264201A1 (en) 2014-05-21 2017-01-12 New York University Oxopiperazine helix mimetics for control of hypoxia-inducible gene expression
WO2023122481A2 (en) * 2021-12-20 2023-06-29 Sigma-Aldrich Co. Llc Chemical linkers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926472A1 (de) * 1979-06-30 1981-01-15 Thomae Gmbh Dr K Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
ZA825719B (en) * 1981-09-03 1983-06-29 Recordati Chem Pharm Alkanoylanilides
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
US4895846A (en) * 1984-04-11 1990-01-23 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4332168A1 (de) * 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4326344A1 (de) * 1993-08-05 1995-02-09 Thomae Gmbh Dr K Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CA2171850A1 (en) * 1994-07-15 1996-02-01 Kiyoaki Katano Novel compound having platelet aggregation inhibitor effect
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives

Also Published As

Publication number Publication date
AR002950A1 (es) 1998-05-27
TR199501634A2 (tr) 1996-07-21
EP0799202A1 (de) 1997-10-08
CZ189197A3 (cs) 1998-01-14
NO972881L (no) 1997-06-20
SK79797A3 (en) 1997-11-05
IL116517A0 (en) 1996-03-31
CA2207618A1 (en) 1996-07-04
FI972646A0 (fi) 1997-06-19
HRP950609A2 (en) 1997-10-31
PL321003A1 (en) 1997-11-24
BR9510360A (pt) 1997-12-23
MX9704745A (es) 1997-10-31
EE9700141A (et) 1997-12-15
FI972646A (fi) 1997-08-19
AU4432496A (en) 1996-07-19
CN1183770A (zh) 1998-06-03
WO1996020173A1 (de) 1996-07-04
US5922717A (en) 1999-07-13
NO972881D0 (no) 1997-06-20
JPH10511374A (ja) 1998-11-04

Similar Documents

Publication Publication Date Title
BG101582A (en) Piperazine derivatives, medicaments containing the same, their use and process for preparing the same
MX9700020A (es) Derivados ciclicos de una urea, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
HUP9901820A3 (en) 4-amino pyrimidine derivatives, medicaments containing these compounds, their use and process for their production
HUT70848A (en) 1-aminoethyl-indol derivatives, process for production thereof and pharmaceutical compositions comprising them
MY118498A (en) Lactam derivatives
NO923466L (no) Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
AU3822293A (en) Cyclic imino derivatives
HUT68092A (en) Substituted heterocyclyl isoquinolinium salts, process for their production and pharmaceutical compositions containing the same
HUT59140A (en) Process for producing imidzoles condensed with heterocyclic group, as well as pharmaceutical compositions comprising same
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
NZ325235A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
HU9802143D0 (en) New heterocyclic compounds of 5 members in the ring, process for producing them and pharmaceutical compositions containing them
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
ZA911538B (en) New benzimidazole derivatives,process for their production and their pharmaceutical use
PL316870A1 (en) Derivatives of 5-heterocyclo 1,5-benzodiazepine
IL124341A0 (en) Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
ES2143224T3 (es) Derivados naftamida de 3-beta-amino azabiciclo octano o nonano, como agentes antipsicoticos.
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.
AU2912097A (en) Novel piperazine or homopiperazine derivatives, pharmaceutical compositions containing the same and process for their preparation
SI1165528T1 (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika